"UNVEILING THE IMPACT OF DIABETES ON BLOOD AND BIOCHEMICAL PARAMETERS: A CROSS-SECTIONAL STUDY AT LUMHS, JAMSHORO"
Main Article Content
Keywords
.
Abstract
Background: Diabetes mellitus (DM) is a prevalent chronic metabolic disorder characterized by elevated blood glucose levels, which can lead to severe complications affecting multiple organ systems. In Pakistan, the prevalence of diabetes has increased significantly, necessitating comprehensive evaluation of diabetes-related complications and associated biochemical markers.
Objective: This study aimed to evaluate the effects of diabetes on various blood and biochemical parameters in patients at Liaquat University of Medical and Health Sciences (LUMHS), Jamshoro, to provide insights that can inform clinical practice and public health strategies.
Methods: A cross-sectional study was conducted involving 400 participants, divided into diabetic and non-diabetic groups. Fasting blood glucose (FBG), body mass index (BMI), waist circumference, uric acid, urea, creatinine, and complete blood count (CBC) parameters were measured. Statistical analysis, including t-tests and correlation analysis, was performed to assess the differences and relationships between groups and variables.
Results: Diabetic patients showed significantly higher levels of FBG, uric acid, and waist circumference compared to non-diabetic participants (p < 0.05). BMI and waist circumference were strongly correlated with FBG in the non-diabetic group but were weaker in the diabetic group, suggesting altered metabolic regulation in diabetic individuals. Gender differences were observed, with males having higher RBC and PCV levels, while females had higher BMI and waist circumference. Uric acid levels were also higher in males, correlating with a higher risk of cardiovascular complications.
Conclusions: The study highlights significant differences in metabolic and hematological profiles between diabetic and non-diabetic individuals, emphasizing the importance of regular monitoring of biochemical parameters for effective management of diabetes. The findings also suggest the need for gender-specific strategies in diabetes care to address the distinct metabolic challenges faced by males and females. Further research is needed to explore the mechanisms underlying these metabolic alterations and their impact on diabetes progression and complications.
References
2. Khan M, Akram Z, Siddiqui S, Islam N. Prevalence of diabetes and associated risk factors in a rural area of Sindh, Pakistan. J Diabetol. 2019;10(2):70-75.
3. Basit A, Fawwad A, Qureshi H, Shera AS. Prevalence of diabetes, pre-diabetes and associated risk factors: second National Diabetes Survey of Pakistan (NDSP), 2016-2017. BMJ Open. 2018 Jul 3;8(8).
4. Saeed K, Alvi FY, Jehan S, Ullah H, Zeeshan F, Shafiq M, et al. Correlation of HbA1c and fasting blood glucose with blood pressure in type 2 diabetes mellitus. Cureus. 2019;11(3).
5. Shera AS, Jawad F, Maqsood A. Prevalence of diabetes in Pakistan. Diabetes Res Clin Pract. 2007;76(2):219-222.
6. Wang Y, Montani JP, Yang Z, Xiang L. Contribution of fasting glucose and post-load glucose to HbA1c in the general population. Clin Chim Acta. 2019;495:131-134.
7. Dobbins RL, Trujillo ME, Crackower MA, Jiao A, Goldstein BJ, O'Neill EA, et al. Global effects of an insulin sensitizer in genetically obese mice: a system approach. Endocrinology. 2018;159(1):219-236.
8. Johnson RJ, Nakagawa T, Sanchez-Lozada LG, Shafiu M, Sundaram S, Le M, et al. Sugar, uric acid, and the etiology of diabetes and obesity. Diabetes. 2013;62(10):3307-3315.
9. Kuwabara M, Niwa K, Nishihara S, Nishi Y, Mizuno A, Asano T, et al. Relationship between serum uric acid levels and hypertension among Japanese individuals not treated for hyperuricemia and hypertension. Hypertens Res. 2014;37(8):785-789.
10. Lv Q, Meng XF, He FF, Chen S, Su H, Xiong J, et al. High serum uric acid and increased risk of type 2 diabetes: A systemic review and meta-analysis of prospective cohort studies. PLoS One. 2013;8(2).
11. Van Buren PN, Toto R. Hypertension in diabetic nephropathy: epidemiology, mechanisms, and management. Adv Chronic Kidney Dis. 2011;18(1):28-41.
12. Fox CS, Larson MG, Leip EP, Culleton B, Wilson PW, Levy D. Predictors of new-onset kidney disease in a community-based population. JAMA. 2004;291(7):844-850.
13. Loutradis C, Skodra A, Sarafidis P, Papadopoulos C, Zanos S, Alexandrou M, et al. Diabetes mellitus increases the prevalence of anemia in patients with chronic kidney disease: A nested case-control study. World J Nephrol. 2016;5(4):358-366.
14. Sinha N, Kumar V, Kumar R, Bhattacharya S. Hematological profile in diabetes and its association with diabetic microvascular complications. J Assoc Physicians India. 2018;66(3):26-29.
15. Roglic G, Norris SL. Diabetes complications in sub-Saharan Africa: the need for a comprehensive approach. J Diabetes Complications. 2017;31(7):945-948.
16. Muniyappa R, Lee S, Chen H, Quon MJ. Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and use of new techniques. Am J Physiol Endocrinol Metab. 2008 Jan;294(1).
17. American Diabetes Association. Standards of medical care in diabetes—2021. Diabetes Care. 2021;44(Suppl 1).
18. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, et al. Heart disease and stroke statistics—2013 update: a report from the American Heart Association. Circulation. 2013;127(1).
19. Gallagher EJ, LeRoith D. Obesity and diabetes: the increased risk of cancer and cancer-related mortality. Physiol Rev. 2015 Apr;95(3):727-748.
20. Grundy SM. Metabolic syndrome update. Trends Cardiovasc Med. 2016;26(4):364-373.
21. Rosenquist KJ, Pedley A, Massaro JM, Therkelsen KE, Murabito JM, Hoffmann U, et al. Visceral and subcutaneous fat quality and cardiometabolic risk. J Am Coll Cardiol. 2013;62(8):791-799.
22. Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature. 2006 Dec;444(7121):840-846.
23. Rizza RA, Mandarino LJ, Gerich JE. Mechanism and significance of insulin resistance in non-insulin-dependent diabetes mellitus. Diabetes. 1981 Jun;30(5):990-995.
24. Dehghan A, van Hoek M, Sijbrands EJ, Hofman A, Witteman JC. High serum uric acid as a novel risk factor for type 2 diabetes. Diabetes Care. 2008 Feb;31(2):361-362.
25. Sautin YY, Nakagawa T, Zharikov S, Johnson RJ. Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative/nitrosative stress. Am J Physiol Cell Physiol. 2007 Nov;293(5).
26. Maruhashi T, Nakashima A, Soga J, Fujimura N, Idei N, Mikami S, et al. Hyperuricemia is strongly associated with endothelial dysfunction in large and resistance arteries in humans. Hypertension. 2016 Nov;68(5):1184-1191.
27. Choi HK, Atkinson K, Karlson EW, Willett W, Curhan G. Purine-rich foods, dairy and protein intake, and the risk of gout in men. N Engl J Med. 2004 Mar;350(11):1093-1103.
28. Madero M, Sarnak MJ, Wang X, Sushrut S, Muntner P, Fox CS, et al. Uric acid and long-term outcomes in CKD. Am J Kidney Dis. 2009 Aug;54(5):806-814.
29. Varlamov O, Bethea CL, Roberts CT Jr. Sex-specific differences in lipid and glucose metabolism. Front Endocrinol (Lausanne). 2015 Mar;5:241.
30. Pickup JC, Crook MA. Is type II diabetes mellitus a disease of the innate immune system? Diabetologia. 1998 Sep;41(10):1241-1248.
31. Schiffrin EL, Lipman ML, Mann JF. Chronic kidney disease: effects on the cardiovascular system. Circulation. 2007 Jul;116(1):85-97.
32. Festa A, D'Agostino R Jr, Howard G, Mykkänen L, Tracy RP, Haffner SM. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation. 2000 Jul;102(1):42-47.
33. Schalkwijk CG, Stehouwer CD. Vascular complications in diabetes mellitus: the role of endothelial dysfunction. Clin Sci (Lond). 2005 Apr;109(2):143-159.